QT
PRVB

Quantbot Technologies’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Quantbot Technologies’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,120
Closed -$22.4K – 2215
2022
Q4 		$22.4K Buy
+2,120
New +$17.1K ﹤0.01% 1427
2021
Q1 		– Sell
-298
Closed -$5K – 1863
2020
Q4 		$5K Buy
+298
New +$4.47K ﹤0.01% 1168
2020
Q1 		– Sell
-1,621
Closed -$24K – 1528
2019
Q4 		$24K Buy
+1,621
New +$14.4K ﹤0.01% 1038

Other funds holding PRVB

SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Quantbot Technologies's PRVB Position: Q1 2023 in Review

Quantbot Technologies sold out of Provention Bio, Inc. Common Stock (PRVB) in Q1 2023, closing a stake of 2,120 shares — an estimated $22.4K sold.

Quantbot Technologies first reported a position in PRVB in Q4 2019 and held it in 3 quarters. The position peaked at $24K in Q4 2019. 182 funds tracked by Wall St. Rank hold PRVB as of Q1 2023.

  • Quantbot Technologies reported no remaining Provention Bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Quantbot Technologies sold 2,120 Provention Bio, Inc. Common Stock shares in Q1 2023, an estimated $22.4K.
  • Quantbot Technologies first reported a position in Provention Bio, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
  • Quantbot Technologies's Provention Bio, Inc. Common Stock position peaked at $24K in Q4 2019.
  • 182 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q1 2023.

Based on Quantbot Technologies's 13F filing for Q1 2023, filed 12 May 2023.